LAT1 Inhibition with JPH203 Modifies Early Cellular Responses to X-Ray Irradiation in TPC-1 Thyroid Cancer Cells
4 affiliations
- 1Department of Radiation Science, Hirosaki University Graduate School of Health Sciences, 66-1, Hon-cho, Hirosaki 036-8564, Japan
- 2Research Center for Biomedical Sciences, Hirosaki University, 66-1, Hon-cho, Hirosaki 036-8564, Japan
- 3Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, SE-106 91 Stockholm, Sweden
- 4Department of Radiology, Aomori Rosai Hospital, Hachinohe 031-8551, Japan
Abstract
The L-type amino acid transporter 1 (LAT1), encoded by the SLC7A5 gene, supports cancer-cell growth and nutrient-sensitive signaling. Although LAT1 inhibition has been reported to enhance radiosensitivity in some cancer models, its role in thyroid cancer radiation responses remains unclear. We investigated the association of SLC7A5 with thyroid differentiation and examined whether JPH203 treatment modifies X-ray responses in TPC-1 thyroid cancer cells. SLC7A5 expression, thyroid differentiation score (TDS), and progression-free interval (PFI) were analyzed using The Cancer Genome Atlas thyroid carcinoma dataset. TPC-1 cells were treated with JPH203 and X-ray irradiation. Clonogenic survival and senescence-associated β-galactosidase signal were assessed as longer-term outcomes, whereas cell-cycle distribution, apoptosis, and ribosomal protein S6 (RPS6) phosphorylation were evaluated during the early post-irradiation period. SLC7A5 expression was inversely correlated with TDS but was not significantly associated with PFI in either the overall cohort or the lower-TDS subgroup. JPH203 reduced clonogenic growth in a concentration-dependent manner but did not enhance X-ray-induced loss of clonogenic survival or senescence-associated β-galactosidase signal. In contrast, JPH203 modified early radiation responses, including G2/M accumulation and apoptotic responses. Combined JPH203 and X-ray treatment also altered total and phosphorylated RPS6 signals. JPH203 treatment modifies early cellular responses to X-ray irradiation in TPC-1 cells, but these changes did not translate into enhanced clonogenic radiosensitivity. These findings highlight a temporal dissociation between early radiation-response phenotypes and long-term reproductive cell survival.
Related
- A-to-I editing modifies the target and role of miR-376a-3p in papillary thyroid cancer
- Gjb2 V37M Modifies Metabolic Responses to Chronic High-Fat Feeding in Mice
- Comparative Transcriptional Responses of Human Blood to Neutron and Photon Irradiation
- PKR inhibition prevents maladaptive responses to endoplasmic reticulum (ER) stress in early-onset dystonia DYT-PRKRA.
- Temporal Integration of Weak Acoustic Stress Leads to Delayed Cellular Responses
BibTeX
@article{kotani2026lat1,
title = {{LAT1 Inhibition with JPH203 Modifies Early Cellular Responses to X-Ray Irradiation in TPC-1 Thyroid Cancer Cells}},
author = {Akihito Kotani and Satoru Monzen and Masaki Tatara and Andrzej Wojcik and Yasushi Mariya},
journal = {International Journal of Molecular Sciences},
year = {2026},
month = nov,
doi = {10.3390/ijms272210248},
url = {https://www.mdpi.com/1422-0067/27/22/10248},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - LAT1 Inhibition with JPH203 Modifies Early Cellular Responses to X-Ray Irradiation in TPC-1 Thyroid Cancer Cells
AU - Akihito Kotani
AU - Satoru Monzen
AU - Masaki Tatara
AU - Andrzej Wojcik
AU - Yasushi Mariya
PY - 2026
DA - 2026/11/15
JO - International Journal of Molecular Sciences
DO - 10.3390/ijms272210248
UR - https://www.mdpi.com/1422-0067/27/22/10248
AB - The L-type amino acid transporter 1 (LAT1), encoded by the SLC7A5 gene, supports cancer-cell growth and nutrient-sensitive signaling. Although LAT1 inhibition has been reported to enhance radiosensitivity in some cancer models, its role in thyroid cancer radiation responses remains unclear. We investigated the association of SLC7A5 with thyroid differentiation and examined whether JPH203 treatment modifies X-ray responses in TPC-1 thyroid cancer cells. SLC7A5 expression, thyroid differentiation score (TDS), and progression-free interval (PFI) were analyzed using The Cancer Genome Atlas thyroid carcinoma dataset. TPC-1 cells were treated with JPH203 and X-ray irradiation. Clonogenic survival and senescence-associated β-galactosidase signal were assessed as longer-term outcomes, whereas cell-cycle distribution, apoptosis, and ribosomal protein S6 (RPS6) phosphorylation were evaluated during the early post-irradiation period. SLC7A5 expression was inversely correlated with TDS but was not significantly associated with PFI in either the overall cohort or the lower-TDS subgroup. JPH203 reduced clonogenic growth in a concentration-dependent manner but did not enhance X-ray-induced loss of clonogenic survival or senescence-associated β-galactosidase signal. In contrast, JPH203 modified early radiation responses, including G2/M accumulation and apoptotic responses. Combined JPH203 and X-ray treatment also altered total and phosphorylated RPS6 signals. JPH203 treatment modifies early cellular responses to X-ray irradiation in TPC-1 cells, but these changes did not translate into enhanced clonogenic radiosensitivity. These findings highlight a temporal dissociation between early radiation-response phenotypes and long-term reproductive cell survival.
SN - 1422-0067
ER -